Taoyuan, Taiwan

Tien-Wang Chiu

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tien-Wang Chiu. Retrieved from https://idiyas.com/inventor/tien-wang-chiu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Tien-Wang Chiu

Introduction

Tien-Wang Chiu is a notable inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for cancer treatment. His work is characterized by a commitment to advancing medical science through innovative solutions.

Latest Patents

Tien-Wang Chiu holds 1 patent. His patent relates to a novel compound extracted from and related compounds of formula (1). This invention includes pharmaceutical compositions comprising the compound of formula (1) and a pharmaceutically acceptable carrier or excipient. Furthermore, the invention outlines a method to inhibit cancer cells by administering an effective amount of the compound of formula (1).

Career Highlights

Throughout his career, Tien-Wang Chiu has demonstrated a strong dedication to research and innovation. His work has the potential to impact cancer treatment significantly, showcasing his expertise in pharmaceutical sciences.

Collaborations

Some of his notable coworkers include Ching-Kuo Lee and Jir-Mehng Lo. Their collaborative efforts contribute to the advancement of research in their field.

Conclusion

Tien-Wang Chiu's innovative work in developing pharmaceutical compounds highlights his role as a key figure in cancer research. His contributions are paving the way for new treatment options and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…